Surgery Partners (NASDAQ:SGRY) Stock Rating Reaffirmed by Cantor Fitzgerald
Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They presently have a $43.00 target price on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 38.00% from the stock’s current price. A number of other […]
6 Oct 08:18 · The Markets Daily